Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
7,025.00    330.00 (4.93%)
Bid:
7,695.00
Ask:
5,695.00
Spread: -2,000.00 (-25.991%)
Market Cap: £4.94b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Acquisition

30 Nov 2016 07:00

RNS Number : 4634Q
Spirax-Sarco Engineering PLC
30 November 2016
 

 

30th November 2016

Spirax Sarco acquires Aflex Hose Limited for £61.4 million

Spirax-Sarco Engineering plc (Spirax Sarco), the world leader in the control and efficient use of steam, and in peristaltic pumping and associated fluid path technologies, announces that it has acquired Aflex Hose Limited and its subsidiary Aflex Hose USA LLC (Aflex) for £61.4 million. 

Aflex, based in Halifax, UK and with a sales and assembly operation in Pennsylvania, USA, specialises in the design and manufacture of PTFE-lined flexible hoses for the pharmaceutical, food, chemical and automotive industries. The business will be integrated into the Watson-Marlow Fluid Technology Group (WMFTG). We are pleased that Rod Anderson, a founder, will continue as a technical advisor and that senior management will remain with the business.

Aflex is highly synergistic with, and a natural extension to, the WMFTG fluid path product portfolio and further strengthens WMFTG's already strong global presence in the biotechnology, pharmaceutical, industrial, chemical and food & beverage sectors. Aflex utilises patented, market-leading technology to produce PTFE-lined flexible hoses, which outperform other PTFE and standard hose types within the most demanding applications, ensuring the highest levels of chemical resistance, superior flexibility and sterility. Aflex's premium PTFE-lined hoses complement our FlowSmart silicone hoses and WMFTG's other fluid path products, as part of our strategy to provide a complete value-added hose and tubing range.

The Aflex brand has a well-established worldwide reputation and the company had net sales of over £23 million in their last financial year, ended August 2016, with underlying EBITDA of £6 million. Post completion, Spirax Sarco will invest in Aflex to further develop its products and routes to market.

The purchase consideration is on a debt free and cash free basis, and will be financed from Spirax Sarco's existing resources. The acquisition will have a negligible impact on Group earnings in the current year but is expected to be a positive contributor from 2017 onwards.

Enquiries:

Nicholas Anderson, Chief Executive

Kevin Boyd, Group Finance Director

Tel: 01242 535234

 

About Spirax Sarco

 

Spirax-Sarco Engineering plc is the world leader in each of its two businesses, Spirax Sarco for steam specialties and Watson‑Marlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies. The steam specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The company helps its customers to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 5,000 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

 

Further information can be found at www.spiraxsarcoengineering.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEASFNASXKFFF
Date   Source Headline
11th Jun 20144:08 pmRNSHolding(s) in Company
6th Jun 20145:41 pmRNSDirector/PDMR Shareholding
5th Jun 20144:31 pmRNSDirector/PDMR Shareholding
5th Jun 20144:04 pmRNSTotal Voting Rights
29th May 20143:43 pmRNSDirector/PDMR Shareholding
23rd May 20144:29 pmRNSDirector/PDMR Shareholding
21st May 20144:29 pmRNSHolding(s) in Company
20th May 20145:50 pmRNSResult of AGM
20th May 20147:00 amRNSInterim Management Statement
7th May 20144:18 pmRNSTotal Voting Rights
30th Apr 20144:59 pmRNSDirector/PDMR Shareholding
17th Apr 20143:40 pmRNSDirector/PDMR Shareholding
8th Apr 20144:25 pmRNSDirector/PDMR Shareholding
2nd Apr 201411:12 amRNSHolding(s) in Company
24th Mar 20144:28 pmRNSAnnual Financial Report
24th Mar 201410:35 amRNSDirector/PDMR Shareholding
11th Mar 20148:30 amRNSDirectorate Change
6th Mar 20147:00 amRNSFinal Results
25th Feb 20147:30 amRNSChange of Director Details
22nd Jan 201411:04 amRNSNotification of Key Dates
6th Jan 20148:36 amRNSAcquisition
3rd Jan 20144:33 pmRNSTotal Voting Rights
16th Dec 20134:10 pmRNSHolding(s) in Company
16th Dec 20139:30 amRNSChange of Auditor
16th Dec 20138:30 amRNSBoard Succession Changes
11th Dec 20132:59 pmRNSDirector/PDMR Shareholding
10th Dec 20139:00 amRNSDirector Declaration
5th Dec 20134:27 pmRNSTotal Voting Rights
29th Nov 20134:21 pmRNSHolding(s) in Company
27th Nov 20134:20 pmRNSDirector/PDMR Shareholding
18th Nov 201312:36 pmRNSDirector/PDMR Shareholding
14th Nov 20134:28 pmRNSDirector/PDMR Shareholding
7th Nov 20137:00 amRNSInterim Management Statement
5th Nov 20134:24 pmRNSTotal Voting Rights
11th Oct 20139:08 amRNSDirector/PDMR Shareholding
2nd Oct 20132:00 pmRNSTotal Voting Rights
2nd Oct 20139:48 amRNSNotification of Release Date - IMS
23rd Sep 20138:41 amRNSHolding(s) in Company
3rd Sep 20138:56 amRNSTotal Voting Rights
30th Aug 20138:00 amRNSAcquisition
22nd Aug 20133:56 pmRNSHolding(s) in Company
13th Aug 20134:28 pmRNSDirector/PDMR Shareholding
8th Aug 20137:00 amRNS2013 Half Year Results
7th Aug 201310:00 amRNSBoard Changes
6th Aug 20134:26 pmRNSTotal Voting Rights
12th Jul 20133:20 pmRNSDates for 2013 Half-Year Results
5th Jul 20135:24 pmRNSDirector/PDMR Shareholding
1st Jul 20133:17 pmRNSTotal Voting Rights
24th Jun 20133:34 pmRNSHolding(s) in Company
31st May 20137:00 amRNSAmendment to Official List

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.